A5071504648- Schizophrenia research and treatment
- Pharmaceutical Practices and Patient Outcomes
- Bipolar Disorder and Treatment
- Mental Health and Psychiatry
- Electroconvulsive Therapy Studies
- Innovations in Medical Education
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Health and Mental Health
- Diet and metabolism studies
- Chronic Disease Management Strategies
- Psychotherapy Techniques and Applications
- Treatment of Major Depression
- Diabetes Treatment and Management
- Mental Health Treatment and Access
- Pharmacology and Obesity Treatment
- Interprofessional Education and Collaboration
- Clinical practice guidelines implementation
- Delphi Technique in Research
- Blood Pressure and Hypertension Studies
- Personality Disorders and Psychopathology
- Attention Deficit Hyperactivity Disorder
- Psychiatric care and mental health services
Saint John of God Hospital
2015-2024
Royal College of Surgeons in Ireland
2019-2024
University College Dublin
2018
St John of God Hospital
2017
Office of the Attorney General
2000
The King's College
2000
Overweight and obesity are highly prevalent in people with severe mental illness (SMI). Antipsychotic-induced weight gain (AIWG) is one of the most commonly reported distressing side effects treatment living SMI place a high value on avoidance this effect. Metformin effective pharmacological intervention studied for prevention AIWG yet clear guidelines lacking evidence has not translated into practice. The aim research was to develop guideline use metformin AIWG.
For approximately one third of individuals treated for psychosis or schizophrenia, antipsychotic medications will have little no therapeutic benefit. Clozapine remains the sole medication approved treatment-resistant and studies demonstrated its superior efficacy in reducing psychotic symptoms.Data were collected from medical records people who originally presented with a first-episode between 1995 1999 (N = 171). Data obtained first presentation up to December 31, 2013 until patient was...
Antipsychotics are associated with a range of side-effects that can influence patients' subjective well-being negatively resulting in poor adherence. In order to limit the negative consequences side-effects, they should be regularly systematically assessed. The aim this study was assess antipsychotic an inpatient cohort using validated rating scales.Eligible individuals prescribed for at least 2 weeks were invited have their assessed systematically.A total 208 side-effects; 71.5% (n = 138)...
<b>Objective.</b> To create a brief, experiential educational intervention for undergraduate pharmacy students aimed at developing appropriate attitudes, knowledge, and skills the delivery of recovery-focused services to people with mental illness, elicit student perceptions value impact intervention. <b>Methods.</b> A brief was developed in which cohort 44 fourth-year attended psychiatric teaching hospital groups 10 to12. The integrated into therapeutics module, based on Fink's taxonomy...
Abstract People with severe mental illness (SMI) have a shorter life expectancy than the rest of population. Multimorbidity and poorer physical health contribute to this inequality. Cardiometabolic multimorbidity confers significant mortality risk in is not restricted older people SMI present earlier life. Despite this, most screening, prevention treatment strategies target people. under 40 years are underserved by current guidelines for cardiovascular assessment reduction. Research needed...
Abstract Medicines optimisation ensures that people get the best possible outcomes from their medicines. As those with severe mental illness (SMI) are frequently prescribed psychotropic medicines potentially significant side-effects, poor adherence to treatment and physical morbidity common. This results in suboptimal symptom control, health problems negative outcomes. The specialist pharmacist (SMHP) is placed provide leadership for inpatient setting. By adopting a patient-centred approach...